NovoSeven RT: payments to doctors
Payments that named NovoSeven RT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $385K
- Providers
- 280
- Transactions
- 523
- Average per transaction
- $736
The per-transaction average — $736 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 280 providers the average total is $1,375, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novo Nordisk | $323,370 | 84.0% |
| Novo Nordisk AS | $34,343 | 8.9% |
| Novo Nordisk Health Care AG | $27,284 | 7.1% |